EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Management of Molar‐Pregnancy and Associated Gestational Trophoblastic Neoplasia at a Specialised Unit: 10‐Year Review

Harrison Odgers iD, Shannon Philp, Trevor Tejada-Berges

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026

DOI: 10.1111/ajo.70053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2026. Verfasst von Harrison Odgers und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecologic Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease, Hydatidiform Mole, Chorionic Gonadotropin, beta Subunit, Human, Uterine Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients diagnosed with gestational trophoblastic diseases (GTD) can develop malignant gestational trophoblastic neoplasia (GTN). ß‐hCG monitoring is important in the early detection of GTN. The primary outcome of this study was to describe ß‐hCG monitoring completion rates and time from GTN diagnosis to chemotherapy commencement for patients cared for by a specialised GTD unit within a Gynecologic Oncology department. Secondary outcomes included imaging findings, quantitative ß‐hCG levels and gestational age at the time of GTD diagnosis, WHO/FIGO scores and chemotherapy outcomes for those who developed GTN, and the time taken for ß‐hCG normalisation for both groups. We collected data for 164 patients with molar pregnancies and 28 patients with GTN requiring chemotherapy. ß‐hCG monitoring completion was 93.9%, and the median time to chemotherapy commencement was 7 days. Additional data found a low risk of GTN diagnosis following a negative ß‐hCG and high complete response rates to chemotherapy for GTN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Trophoblastic DiseaseHydatidiform MoleChorionic Gonadotropin, beta Subunit, HumanUterine NeoplasmsHumansFemalePregnancyAdultRetrospective StudiesYoung AdultGestational Age

Stichwörter der Autor:innen

complete molar pregnancygestational trophoblastic diseasegestational trophoblastic neoplasiahydatidiform molemolar pregnancypartial molar pregnancy

Substanzen

Chorionic Gonadotropin, beta Subunit, Human

Autor:innen und Institutionen

  • Department of Gynaecologic Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
  • Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
  • Susan Wakil School of Nursing and Midwifery, The University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Harrison Odgers

Zitieren

APA

Odgers, H., Philp, S., & Tejada-Berges, T. (2026). Management of Molar‐Pregnancy and Associated Gestational Trophoblastic Neoplasia at a Specialised Unit: 10‐Year Review. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.70053

Vancouver

Odgers H, Philp S, Tejada-Berges T. Management of Molar‐Pregnancy and Associated Gestational Trophoblastic Neoplasia at a Specialised Unit: 10‐Year Review. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026. doi:10.1111/ajo.70053

BibTeX
@article{Odgers2026,
  author = {Odgers, Harrison and Philp, Shannon and Tejada-Berges, Trevor},
  title = {Management of Molar‐Pregnancy and Associated Gestational Trophoblastic Neoplasia at a Specialised Unit: 10‐Year Review},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2026},
  doi = {10.1111/ajo.70053}
}
Kostenlos starten →